Healthcare

INVESTMENT FOCUSING

Access to healthcare may vary across countries, communities, and individuals, influenced by social and economic conditions as well as health policies. Providing health care services means “the timely use of personal health services to achieve the best possible health outcomes”.

Healthcare systems are organizations established to meet the health needs of targeted populations. According to the World Health Organization (WHO), a well-functioning healthcare system requires a financing mechanism, a well-trained and adequately paid workforce, reliable information on which to base decisions and policies, and well maintained health facilities to deliver quality medicines and technologies.

An efficient healthcare system can contribute to a significant part of a country’s economy, development and industrialization. Healthcare is conventionally regarded as an important determinant in promoting the general physical and mental health and well-being of people around the world.

Legacy Prime (Thailand) Company Limited, was established in 2019 with the lead investor: Regal Asset Holding Asia Limited. We focus on the business sector of Cannabis Investment covering: Seeding, Plantation, Medical Research, Manufacturing, Import & Export.

Legacy Prime Holding Co. Ltd.

Since Thailand is the first country in Asia that has approved of the use of Cannabis plants for Medicinal uses; by the Medical Marijuana Legislative Assembly (NLA). The Narcotic Acts changes become law and have been published in the Royal Thai Government gazette. The lifting of restrictions includes Plantation, Production, import, export, possession, and use.

We aim to set up a Joint Venture with eligible Government Organizations, Bureaus, and Ministries, including the “Department and Local Administration” to acquire the license to trade and market in Thailand, Japan and Korea, UK and Europe.

Products The purified form of THC and CBD for medicinal use would be the new organic medical solution for people’s health. In Thailand, THC and CBD are planned to be the key solution to reduce the Country’s cost of importing medicine. There is a high demand for THC and CBD of around 100,000 to 1,000,000 patients in Thailand.

This also has the potential of producing other alkaloids, such as CBA CBN, which are effective for future medicinal uses.

To lead the whole market & ecosystem of Thailand, we will use the most advanced & latest technology for CBD, CBA, CBN, and other alkaloids extraction system which could remove the toxic patricides innovation. data 2019.

Business Location

Thailand

Explore more

Growth Plan
Four phases
Cancer center hospital 40~50 beds
ASIA’S first hospital-tech 150-200 beds
Rehabilitation center & resort
ASIA’S most innovative hospital-tech 400-500 beds